ALPA.NS Alpa Laboratories NSE up 20.00% intraday on 07 Apr 2026: volume spike and price targets

ALPA.NS stock led intraday gains after Alpa Laboratories Limited (NSE) surged 20.00% to INR 62.10 on 07 Apr 2026. The move followed a sharp volume pick-up at 75,621 shares versus an average of 20,846, pushing price to the day’s high of INR 62.10 from an open of INR 52.00. Traders cited improved liquidity, low valuation metrics and technical momentum. We examine fundamentals, technicals, Meyka AI grade and model forecasts to frame short-term targets and risks for intraday and near-term investors.

Intraday move: ALPA.NS stock gains 20.00% on heavy volume

Alpa Laboratories Limited (ALPA.NS) jumped 20.00% intraday to INR 62.10 on 07 Apr 2026. Volume traded reached 75,621, a 3.62x increase over average volume of 20,846, signalling real buying interest. The stock opened at INR 52.00 and hit a day high of INR 62.10 within the same session.

Fundamentals and valuation: ALPA.NS stock metrics

ALPA.NS trades at PE 11.25 with EPS INR 5.52 and market cap INR 1,306,621,260.00. Price-to-book is 0.71, below healthcare sector average PB 2.57, indicating cheapness versus peers. The 50-day average is INR 63.39 and 200-day average is INR 83.10, showing short-term mean reversion risk.

Technical snapshot: ALPA.NS stock indicators

Momentum indicators are mixed: RSI 54.03 and MACD histogram near zero, suggesting a neutral to mildly bullish bias. ATR is 4.25 and Bollinger upper band sits at INR 68.07, giving a near resistance area. ADX at 33.98 signals a strong intraday trend, supporting the current upward move.

Sector context and comparables for ALPA.NS stock

Alpa operates in Healthcare, Drug Manufacturers – Specialty & Generic. The healthcare sector average PE is 36.97, so ALPA.NS’s PE 11.25 looks inexpensive. For peer price action and broader drug sector flow, see recent market pages for Dr Reddy’s and Alkem Investing.com – Dr Reddy’s history and Investing.com – Alkem Laboratories history.

Meyka AI grade and model forecast for ALPA.NS stock

Meyka AI rates ALPA.NS with a score of 72.15 out of 100 (B+, BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly target of INR 69.98 and a yearly target of INR 93.21. Forecasts are model-based projections and not guarantees.

Risks and catalysts affecting ALPA.NS stock

Key risks include inventory and receivables cycles; days sales outstanding is 119.04 and cash conversion cycle is 90.99 days. Interest coverage is weak at -20.53, which needs monitoring despite zero debt reported. Upcoming earnings date is 26 May 2026, a catalyst that could validate the rally or trigger profit-taking.

Final Thoughts

ALPA.NS stock delivered a clear intraday breakout on 07 Apr 2026, rising 20.00% to INR 62.10 on a 75,621 share volume surge. Valuation metrics remain supportive for selective buyers: PE 11.25, PB 0.71, and strong cash per share near INR 66.05. Meyka AI’s forecast model projects a yearly target of INR 93.21, implying an upside of 50.18% from the current INR 62.10. A nearer-term monthly target of INR 69.98 implies an upside of 12.69%. Technicals show a firm intraday trend but resistance near INR 68.07 and the 200-day average at INR 83.10. Traders should watch volume sustainability and receivables cycles. Meyka AI provides this as AI-powered market analysis; forecasts are model projections and not guarantees. Manage position sizing and set stop-losses for intraday trades.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.